Colorectal Cancer Coverage from Every Angle

Recent News

Managing BRAF-Mutant Metastatic Colorectal Cancer in Real-Life Settings
Neoadjuvant Chemoradiotherapy for Rectal Cancer: Treatment Adherence and Outcomes
Combined REMARRY and PURSUIT Trials to Assess Metastatic Colorectal Cancer
Panitumumab Versus Bevacizumab in Regimens for Metastatic Colorectal Cancer
Second-Line Treatment Alternatives for Metastatic Colorectal Cancer
ESMO World GI: Pembrolizumab Plus Ibrutinib Under Study in Metastatic Colorectal Cancer
AACR COVID-19: Are More Patients With Colorectal Cancer Heading to the ER?
ESMO World GI: Trifluridine/Tipiracil-Based Regimen for Metastatic Colorectal Cancer
AACR II: Does Folate Intake Affect Colon Cancer Risk?
ESMO World GI: Second-Line FOLFIRI Chemotherapy Plus Aflibercept in Metastatic Colorectal Cancer
ESMO World GI: Quality of Life and Outcomes With First-Line Chemotherapy for Metastatic Colorectal Cancer
AACR II: Differences in Colorectal Cancer Screening Among Diverse Black Population
ESMO World GI: Early Results With Novel Combination for Metastatic Colorectal Cancer
AACR II: Dual-Targeted Treatment With Radiotherapy for Locally Advanced Rectal Cancer
ESMO World GI: PI3K Inhibitor Plus Cetuximab Under Study in Metastatic Colorectal Cancer
AACR II: Latino Colorectal Cancer Consortium Findings on Genetic Ancestry and Mutations
Pembrolizumab Approved by FDA in First-Line Treatment of MSI-H/dMMR Colorectal Cancer
AACR II: Potential Link Between Dietary Fruit, Fiber and Colorectal Cancer Risk?
ASCO20: Immunotherapy Duo Plus Chemotherapy in Microsatellite-Stable Metastatic CRC
VEGFR Inhibitor Fruquintinib Receives Fast Track Designation for Metastatic Colorectal Cancer
ASCO20: Preoperative Short-Course Radiotherapy Before Chemotherapy in Locally Advanced Rectal Cancer
ASCO20: Trastuzumab Deruxtecan in HER2-Expressing Metastatic Colorectal Cancer
ASCO20: Adding Celecoxib to Standard Chemotherapy in Stage III Colon Cancer
Therapeutic Target IDO1 and Radiation Effects in Colorectal Cancer
ASCO20: Adding Panitumumab to First-Line Regimens in Older Patients With Metastatic Colorectal Cancer
ASCO20: Final IDEA Results on Adjuvant CAPOX for Stage III Colon Cancer
ASCO20: Updated Survival Results With Encorafenib/Cetuximab in Metastatic Colorectal Cancer
ASCO20 Preview: Should Pembrolizumab Replace Chemotherapy in First-Line Treatment of Some Colorectal Cancers?
DDW 2020: Impact of Aspirin/NSAID Use on Survival in Colorectal Cancer
DDW 2020: Risk Association of Rheumatoid Arthritis and Colorectal Cancer
DDW 2020: Antibiotics and Risk of Colorectal Cancer After Negative Colonoscopy
Earlier Screening for Colorectal Cancer Based on Family History
DDW 2020: One-Stop Multicancer Screening Program
High Folate Intake and Colorectal Cancer Risk
DDW 2020: Does Obesity Play a Role in the Development of Colorectal Cancer?
DDW 2020: Differentiating Characteristics of Early-Onset Colorectal Cancer
DDW 2020: ctDNA in Diagnosis of Colorectal Cancer
DDW 2020: Impact of Anticoagulation on Colorectal Cancer Mortality
DDW 2020: Early-Onset Colorectal Cancer and Risk for Second Primary Malignancy
DDW 2020: Can Phosphodiesterase-5 Inhibitors Reduce the Risk of Colorectal Cancer?
AACR 2020: Can Aspirin Decrease the Rate of Metastasis in BRAF-Mutant Colorectal Cancer?
Pembrolizumab Receives FDA Accelerated Approval for Alternative Dosing Schedule
COVID-19 and Colorectal Cancer: A Glimpse at the Italian Experience
HER2-Targeted Therapy With Trastuzumab Deruxtecan in Colorectal Cancer
Encorafenib/Cetuximab Receives FDA Approval in BRAF V600E–Mutated Metastatic Colorectal Cancer
Biomarker-Driven Use of Temozolomide in Metastatic Colorectal Cancer
Racial Differences and Clinical Outcomes in Colorectal Cancer
Neoadjuvant Pembrolizumab Plus Radiotherapy for Rectal Cancer
Using ctDNA to Predict Response to Chemotherapy in Colon Cancer
Molecular Profile and Treatment Response in Locally Advanced Rectal Cancer
Alterations in CAPOX Regimen and Neuropathy
FDA Accepts Biologics License Application for Proposed Biosimilar to Bevacizumab
Does Age Influence Receipt of Second-Line Therapy in Metastatic Colorectal Cancer?
TAPUR Results for Cobimetinib Plus Vemurafenib in Colorectal Cancer
GI Cancers Symposium 2020: AVETUX Regimen in Metastatic Colorectal Cancer
GI Cancers Symposium 2020: Risk of Recurrence With Nonoperative Management of Rectal Cancer
ASCO-SITC 2020: Genetics Research Hints at Regulator of T-Cell Responses in Colorectal Cancer
GI Cancers Symposium 2020: Pertuzumab Plus Trastuzumab in HER2-Positive Colorectal Cancer
GI Cancers Symposium 2020: Does Primary Tumor Resection Before Surgery Improve Survival in Advanced Colorectal Cancer?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.